Article Versions Notes

Ferro M, Ungaro P, Cimmino A, Lucarelli G, Busetto GM, Cantiello F, Damiano R, Terracciano D. Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS). International Journal of Molecular Sciences. 2017; 18(6):1146. https://doi.org/10.3390/ijms18061146

Ferro, Matteo, Paola Ungaro, Amelia Cimmino, Giuseppe Lucarelli, Gian Maria Busetto, Francesco Cantiello, Rocco Damiano, and Daniela Terracciano. 2017. "Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)" International Journal of Molecular Sciences 18, no. 6: 1146. https://doi.org/10.3390/ijms18061146

Ferro, M., Ungaro, P., Cimmino, A., Lucarelli, G., Busetto, G. M., Cantiello, F., Damiano, R., & Terracciano, D. (2017). Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS). International Journal of Molecular Sciences, 18(6), 1146. https://doi.org/10.3390/ijms18061146